In a Pharmalot interview, money manager, blogger, and diabetic David Kliff absolutely excoriates “Buttah Queen” Paula Deen and insulin-maker Novo Nordisk...
Read More
From heartwire: Reported ambivalence about enrolling patients in the TIDE trial, a head-to-head study of rosiglitazone (Avandia; GSK) and pioglitazone (Actos; Takeda)...
Read More
(With apologies for “Repurposing.”) Largely because of a controversial 2007 meta-analysis by the controversial and controversy-stirring Steve Nissen, sales...
Read MoreOn October 18, Pfizer publicly announced its decision to stop selling Exubera, the first inhalable human insulin approved by the FDA, because of poor market...
Read More